Goldman Sachs Maintains Buy on Johnson & Johnson, Raises Price Target to $240

Benzinga · 12/19/2025 17:01
Goldman Sachs analyst Asad Haider maintains Johnson & Johnson (NYSE:JNJ) with a Buy and raises the price target from $213 to $240.